Should I buy MaxLinear, Inc. (MXL) stock or is it too late?

MaxLinear, Inc. · Information Technology · price $89

See the full MaxLinear, Inc. (MXL) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Stifel — 59% of its targets hit on this sector (194 calls tested). It aims for $120 (+35 %), call made on July 25, 2026, maturing on July 25, 2027 (81 d ago).

The 1 reliable analyst $120+35 %

The 5 other firms $95+7.2 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $120 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on MaxLinear, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Benchmark	59 %	+58.5 %	17	$28 -68%
Stifel	72 %	+57.1 %	18	$120 +35%
Roth Capital	67 %	+54.1 %	6	$100 +13%
Northland Capital Markets	60 %	+30.6 %	5	$28 -69%
Deutsche Bank	67 %	+19.5 %	9	$45 -49%
Needham	44 %	+4.2 %	18	$100 +13%
Susquehanna	33 %	-20.3 %	9	$80 -10%

In short — Should you invest in MaxLinear, Inc.? Is it too late, still worth it? Analysts are fairly positive (67% buy, median target $98, i.e. +10%), and the most reliable on MXL targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

67% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
Median price target $98, i.e. +10% from the current price ($89).
The most reliable firm on MXL, Stifel (72% hit rate, 18 scored calls), targets $120 (call made on July 24, 2026, maturing on July 24, 2027) (+35%) in its most recent call, and $49 (call made on April 24, 2026, maturing on April 24, 2027) (-45%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 6 ratings, 2 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on MXL

Median target $98 (+10%) · 6 ratings · Buy consensus

Strong Buy00%

Buy467%

Hold233%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in MaxLinear, Inc. now?

We won't decide for you. The facts: 67% of analysts rate it a buy, median target $98 (+10%), and Stifel (most reliable on MXL, 72%) targets $120. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in MaxLinear, Inc.?

Not according to analysts: the median target ($98) is still +10% above the current price ($89) (most reliable on MXL: Stifel, 72%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is MaxLinear, Inc. still worth investing in?

It depends on the gap between the price ($89) and its estimated value: analysts target $98 on median (+10%), with 67% buys (most reliable on MXL: Stifel, 72%). Cross-check with their real reliability on MXL and the cautions above. Information, not advice.

What's the main risk in buying MXL?

The consensus is not unanimous: of 6 ratings, 2 are neutral.

→ Go deeper: the full MaxLinear, Inc. profile (consensus, analyst reliability, price target, performance).